Similar articles for PMID: 25985906

Year	Number of Results
1800	1
1805	1
1987	1
2002	1
2005	1
2006	5
2007	6
2009	4
2010	3
2011	4
2012	7
2013	2
2014	4
2015	20
2016	7
2017	9
2018	6
2019	5
2020	3
2022	2
2024	0

1

Gilbert PB, Gabriel EE, Hudgens MG, Miao X, Li X, Su SC, Parrino J, Chan IS. Gilbert PB, et al. J Infect Dis. 2015 Nov 1;212(9):1521-3. doi: 10.1093/infdis/jiv287. Epub 2015 May 17. J Infect Dis. 2015. PMID: 25985906 Free PMC article. No abstract available.

2

Correlates of Protection for Herpes Zoster Vaccine: Evaluating Candidate Immunological Variables.

Dunning AJ. Dunning AJ. J Infect Dis. 2015 Nov 1;212(9):1521. doi: 10.1093/infdis/jiv286. Epub 2015 May 17. J Infect Dis. 2015. PMID: 25985903 No abstract available.

3

Assessing correlates of protection in vaccine trials.

Wittes J. Wittes J. J Infect Dis. 2014 Nov 15;210(10):1523-5. doi: 10.1093/infdis/jiu283. Epub 2014 May 13. J Infect Dis. 2014. PMID: 24823622 No abstract available.

4

Fold rise in antibody titers by measured by glycoprotein-based enzyme-linked immunosorbent assay is an excellent correlate of protection for a herpes zoster vaccine, demonstrated via the vaccine efficacy curve.

Gilbert PB, Gabriel EE, Miao X, Li X, Su SC, Parrino J, Chan IS. Gilbert PB, et al. J Infect Dis. 2014 Nov 15;210(10):1573-81. doi: 10.1093/infdis/jiu279. Epub 2014 May 13. J Infect Dis. 2014. PMID: 24823623 Free PMC article. Clinical Trial.

5

Varicella-zoster virus-specific antibody responses in 50-59-year-old recipients of zoster vaccine.

Levin MJ, Schmader KE, Gnann JW, McNeil SA, Vesikari T, Betts RF, Keay S, Stek JE, Bundick ND, Su SC, Zhao Y, Li X, Chan IS, Annunziato PW, Parrino J. Levin MJ, et al. J Infect Dis. 2013 Nov 1;208(9):1386-90. doi: 10.1093/infdis/jit342. Epub 2013 Aug 1. J Infect Dis. 2013. PMID: 23908486 Free PMC article. Clinical Trial.

6

Immunogenicity and safety of an adjuvanted herpes zoster subunit candidate vaccine in adults ≥ 50 years of age with a prior history of herpes zoster: A phase III, non-randomized, open-label clinical trial.

Godeaux O, Kovac M, Shu D, Grupping K, Campora L, Douha M, Heineman TC, Lal H. Godeaux O, et al. Hum Vaccin Immunother. 2017 May 4;13(5):1051-1058. doi: 10.1080/21645515.2016.1265715. Epub 2017 Jan 9. Hum Vaccin Immunother. 2017. PMID: 28068212 Free PMC article. Clinical Trial.

7

Q: Who should receive the shingles vaccine?

Singh A, Englund K. Singh A, et al. Cleve Clin J Med. 2009 Jan;76(1):45-8. doi: 10.3949/ccjm.75a.08046. Cleve Clin J Med. 2009. PMID: 19122110 Free article. No abstract available.

8

The immunogenicity and safety of zoster vaccine in Taiwanese adults.

Yao CA, Chen LK, Huang KC. Yao CA, et al. Vaccine. 2015 Mar 24;33(13):1515-7. doi: 10.1016/j.vaccine.2015.01.085. Epub 2015 Feb 11. Vaccine. 2015. PMID: 25681662

9

Zoster vaccine: current status and future prospects.

Oxman MN. Oxman MN. Clin Infect Dis. 2010 Jul 15;51(2):197-213. doi: 10.1086/653605. Clin Infect Dis. 2010. PMID: 20550454 Review.

10

Comparison of intramuscular and subcutaneous administration of a herpes zoster live-attenuated vaccine in adults aged ≥50 years: a randomised non-inferiority clinical trial.

Diez-Domingo J, Weinke T, Garcia de Lomas J, Meyer CU, Bertrand I, Eymin C, Thomas S, Sadorge C. Diez-Domingo J, et al. Vaccine. 2015 Feb 4;33(6):789-95. doi: 10.1016/j.vaccine.2014.12.024. Epub 2014 Dec 30. Vaccine. 2015. PMID: 25555381 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

82 results

Results by year